Just two weeks after the Senate confirmed Scott Gottlieb as the next Food and Drug Administration commissioner, he returned to face Congress.
The event was slated to be a dry appropriations subcommittee hearing on the FDA budget — but Gottlieb had other things in mind.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,